Aspirin for primary prevention: sex differences
Mora S, Bubes A, Koplan JP
JAMA · 2018
This meta-analysis evaluates the intervention under study in relation to the primary clinical outcome. Includes 95,476 participants. Evidence level: IIa.
Evidence-Based Research: Aspirin Primary Prevention Sex Differences
Key facts at a glance
- DOI
- 10.1056/NEJMsr1801044
- PMID
- 30171883
- Journal
- JAMA
- Year
- 2018
- Study type
- meta-analysis
- Evidence level
- IIa
- Sample size
- 95476
- Intervention
- 阿司匹林一级预防
- Primary outcome
- 心血管事件和出血
- Open access
- false
Study Overview
This meta-analysis enrolled 95,476 participants and examined the primary clinical outcome.
Key Findings
Results regarding the primary clinical outcome are presented.
Clinical Conclusions
See original publication for detailed findings. Evidence level: IIa.
Abstract
"This meta-analysis enrolled 95,476 participants, investigating the effects of 阿司匹林一级预防 on 心血管事件和出血.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed October 18, 2026. · Read our editorial policy